CORMEDIX INC. (CRMD) Return on equity 2016–2025
CORMEDIX INC. (CRMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
40.2%FY2025 · since FY2016: -138.3% → 40.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 40.2% | +61.4 pp |
| FY2024 | -21.2% | — |
| FY2022 | -53.9% | -9.0 pp |
| FY2021 | -44.9% | +4.9 pp |
| FY2020 | -49.8% | +19.7 pp |
| FY2019 | -69.5% | +474.2 pp |
| FY2018 | -543.7% | -84.8 pp |
| FY2017 | -458.9% | -320.6 pp |
| FY2016 | -138.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CRMD financial trends
CRMD RevenueCRMD Net incomeCRMD Net marginCRMD Gross profitCRMD Gross marginCRMD Operating incomeCRMD Operating marginCRMD Operating cash flowCRMD Free cash flowCRMD Capital expendituresCRMD Stock buybacksCRMD Dividends paidCRMD Total assetsCRMD Total liabilitiesCRMD Shareholders’ equityCRMD overview →